The mRNA vaccines we are currently using are not sufficient to stop the ongoing Covid-19 pandemic. Although they have been critical in the fight against SARS-CoV-2, they suffer from a glaring ...

New research has advanced COVID-19 vaccine work in several ways: using a modified live attenuated mumps virus for delivery, showing that a more stable coronavirus spike protein stimulates a stronger ...

DEAR DR. ROACH: You mentioned in a recent column that there is no single-dose measles vaccine. I understand that there are people who object to the MMR combo in the belief that it exposes the child to ...

Vaccination against viruses commonly uses viral proteins to induce an immune response. The vaccine presents the viral proteins as the antigen to which the immune system responds. During natural viral ...

The WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC) continues to closely monitor the genetic and antigenic evolution of SARS-CoV-2 variants, immune responses to SARS-CoV-2 ...

Silencing mRNA expression in dendritic cells did not impair T‑cell priming, including for SARS‑CoV‑2 antigens, suggesting that cross‑presentation by other cell types is sufficient to initiate immunity ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today ...

MUC1 is a mucin protein overexpressed and abnormally glycosylated in many epithelial cancers. Although it is considered a potential target for vaccine development, its effectiveness is limited by its ...